Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Li-Jun Zhang

Showing results (301-310 of 338) with videos related to

Pageof 34
Sort By:
Fitoterapia|March 13, 2024
New sesquiterpenoids with neuroprotective effects in vitro and in vivo from the Picrasma chinensisXian-Zhe Fan, Jia-Qi Song, Xin-Yi Shi, et al.
Frontiers in Microbiology|June 24, 2021
Pleural Fluid GSDMD Is a Novel Biomarker for the Early Differential Diagnosis of Pleural EffusionPu Li, Jing Shi, Lijing Zhou, et al.
Frontiers in Pharmacology|February 11, 2020
ErHuang Formula Improves Renal Fibrosis in Diabetic Nephropathy Rats by Inhibiting CXCL6/JAK/STAT3 Signaling PathwayYu-Li Shen, Yi-Ping Jiang, Xiao-Qin Li, et al.
Frontiers in Pharmacology|December 6, 2021
Corrigendum: ErHuang Formula Improves Renal Fibrosis in Diabetic Nephropathy Rats by Inhibiting CXCL6/JAK/STAT3 Signaling PathwayYu-Li Shen, Yi-Ping Jiang, Xiao-Qin Li, et al.
Biochemical Pharmacology|March 18, 2024
Dbl family RhoGEFs in cancer: different roles and targeting strategiesXin-Yi Chen, Ao-Yu Cheng, Zi-Ying Wang, et al.
Pharmacological Research|November 16, 2023
Neutrophils as potential therapeutic targets for breast cancerYi-Ting Gong, Li-Jun Zhang, Yi-Chen Liu, et al.
Scientific Reports|July 27, 2017
Knockdown of anion exchanger 2 suppressed the growth of ovarian cancer cells via mTOR/p70S6K1 signalingLi-Jun Zhang, Renquan Lu, Ya-Nan Song, et al.
Frontiers in Pharmacology|December 2, 2024
Mass balance, metabolism, and pharmacokinetics of [<sup>14</sup>C]amdizalisib, a clinical-stage novel oral selective PI3Kδ inhibitor for the treatment of non-hodgkin's lymphoma, in healthy Chinese volunteersChun-Yang Zhao, Li-Jun Zhang, Chan Sun, et al.
Oncotarget|October 21, 2017
LncSHRG promotes hepatocellular carcinoma progression by activating <i>HES6</i>Ying-Chen Xu, Chao-Jie Liang, Dong-Xin Zhang, et al.
Zhonghua Yi Xue Yi Chuan Xue Za Zhi = Zhonghua Yixue Yichuanxue Zazhi = Chinese Journal of Medical Genetics|December 12, 2003
[Establishment of transgenic mice for HRX-EEN fusion gene]Yue-ping Sun, Hui Xiong, Yang Wang, et al.
Pageof 34

Showing results (301-310 of 338) with videos related to

Sort By:
Pageof 34
Fitoterapia|March 13, 2024
New sesquiterpenoids with neuroprotective effects in vitro and in vivo from the Picrasma chinensisXian-Zhe Fan, Jia-Qi Song, Xin-Yi Shi, et al.
Frontiers in Microbiology|June 24, 2021
Pleural Fluid GSDMD Is a Novel Biomarker for the Early Differential Diagnosis of Pleural EffusionPu Li, Jing Shi, Lijing Zhou, et al.
Frontiers in Pharmacology|February 11, 2020
ErHuang Formula Improves Renal Fibrosis in Diabetic Nephropathy Rats by Inhibiting CXCL6/JAK/STAT3 Signaling PathwayYu-Li Shen, Yi-Ping Jiang, Xiao-Qin Li, et al.
Frontiers in Pharmacology|December 6, 2021
Corrigendum: ErHuang Formula Improves Renal Fibrosis in Diabetic Nephropathy Rats by Inhibiting CXCL6/JAK/STAT3 Signaling PathwayYu-Li Shen, Yi-Ping Jiang, Xiao-Qin Li, et al.
Biochemical Pharmacology|March 18, 2024
Dbl family RhoGEFs in cancer: different roles and targeting strategiesXin-Yi Chen, Ao-Yu Cheng, Zi-Ying Wang, et al.
Pharmacological Research|November 16, 2023
Neutrophils as potential therapeutic targets for breast cancerYi-Ting Gong, Li-Jun Zhang, Yi-Chen Liu, et al.
Scientific Reports|July 27, 2017
Knockdown of anion exchanger 2 suppressed the growth of ovarian cancer cells via mTOR/p70S6K1 signalingLi-Jun Zhang, Renquan Lu, Ya-Nan Song, et al.
Frontiers in Pharmacology|December 2, 2024
Mass balance, metabolism, and pharmacokinetics of [<sup>14</sup>C]amdizalisib, a clinical-stage novel oral selective PI3Kδ inhibitor for the treatment of non-hodgkin's lymphoma, in healthy Chinese volunteersChun-Yang Zhao, Li-Jun Zhang, Chan Sun, et al.
Oncotarget|October 21, 2017
LncSHRG promotes hepatocellular carcinoma progression by activating <i>HES6</i>Ying-Chen Xu, Chao-Jie Liang, Dong-Xin Zhang, et al.
Zhonghua Yi Xue Yi Chuan Xue Za Zhi = Zhonghua Yixue Yichuanxue Zazhi = Chinese Journal of Medical Genetics|December 12, 2003
[Establishment of transgenic mice for HRX-EEN fusion gene]Yue-ping Sun, Hui Xiong, Yang Wang, et al.
Pageof 34